{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:42:40Z","timestamp":1791117760042,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":42,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003231","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:18:21Z","timestamp":1069384701000},"source":"Crossref","is-referenced-by-count":44,"title":["Intravesical Bacillus Calmette-Gu\u00e9rin versus mitomycin C for Ta and T1 bladder cancer"],"prefix":"10.1002","author":[{"given":"Mike","family":"Shelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Court","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kynaston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"key":"10.1002\/14651858.CD003231-BIB1|cit1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-5347(01)65673-8","article-title":"A randomised multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Gu\u00e9rin","volume":"156","author":"Krege","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB2|cit2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1078-1439(95)00041-F","volume":"1","author":"Lamm","year":"1995","journal-title":"Urological Oncology"},{"key":"10.1002\/14651858.CD003231-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(01)61607-0","article-title":"5-Year follow-up of a randomised prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma","volume":"161","author":"Malmstrom","year":"1999","journal-title":"Journal of Urology"},{"issue":"suppl 5","key":"10.1002\/14651858.CD003231-BIB4|cit4","first-page":"Abstract 119","article-title":"A multicenter and randomised prospective study comparing three intravesical therapies, two with Bacillus Calmette-Guerin and one with mitomycin C chemotherapy in medium and low risk superficial bladders tumours","volume":"39","author":"Nogueira March","year":"2001","journal-title":"Eurpean Urology"},{"key":"10.1002\/14651858.CD003231-BIB5|cit5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000471653","article-title":"Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guerin) in superficial bladder cancer","volume":"20","author":"Rintala","year":"1991","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD003231-BIB6|cit6","first-page":"10","article-title":"Update on the Dutch Cooperative Trial: Mitomycin C versus Bacillus Calmette-Guerin-Tice versus bacillus Calmette-Guerin RIVM in the treatment of patients with pTa - pT1 papillary carcinoma and carcinoma in situ of the urinary bladder","volume":"14","author":"Witjes","year":"1996","journal-title":"Seminars in Urologic Oncology"},{"key":"10.1002\/14651858.CD003231-BIB7|cit7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-4295(98)00212-X","article-title":"Long-term follow-up of an EORTC randomised prospective trial comparing intravesical bacille Calmette-Guerin and mitomycin C in superficial bladder cancer","volume":"52","author":"Witjes","year":"1998","journal-title":"Urology"},{"key":"10.1002\/14651858.CD003231-BIB8|cit8","first-page":"435","article-title":"BCG (RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer","volume-title":"Therapeutic Progress in Urological Cancers","author":"Debruyne","year":"1989"},{"key":"10.1002\/14651858.CD003231-BIB9|cit9","first-page":"511","article-title":"BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer","volume-title":"EORTC Genitourinary Group Monograph 5: Progress and Controversies in Oncological Urology II","author":"Debruyne","year":"1988"},{"issue":"Suppl","key":"10.1002\/14651858.CD003231-BIB10|cit10","first-page":"20","article-title":"BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of a randomised prospective trial","volume":"31","author":"Debruyne","year":"1988","journal-title":"Urology"},{"issue":"suppl","key":"10.1002\/14651858.CD003231-BIB11|cit11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0090-4295(92)90530-A","article-title":"Bacillus Calmette-Gu\u00e9rin versus mitomycin C intravesical therapy in superficial bladder cancer: results of a randomised trial after 21 months of follow-up","volume":"40","author":"Debruyne","year":"1992","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD003231-BIB12|cit12","first-page":"379","article-title":"A randomised and prospective study on the complete response recurrence indices and progression in superficial bladder cancer treated with mitomycin C alone versus mitomycin C and alternating BCG","volume":"46","author":"Gelabert-Mas","year":"1993","journal-title":"Urologia Oncologia 4: Arch Esp de Urol"},{"key":"10.1002\/14651858.CD003231-BIB13|cit13","first-page":"13","article-title":"Immunotherapy (BCG) versus chemotherapy (MMC) in intravesical treatment of superficial bladder cancer","volume-title":"Immunotherapy of Urological Tumours","author":"Jauhiainen","year":"1990"},{"key":"10.1002\/14651858.CD003231-BIB14|cit14","series-title":"Proceedings of the American Urological Association","first-page":"Abstract 734","article-title":"Final report on a randomised multi-centre trial on adjuvant therapy in superficial bladder cancer: TUR only vs TUR + mitomycin vs TUR + bacillus Calmette-Gu\u00e9rin","author":"Krege","year":"1996"},{"key":"10.1002\/14651858.CD003231-BIB15|cit15","series-title":"Journal of Urology","first-page":"275","article-title":"SWOG 8795: A randomised comparison of bacillus Calmette -Guerin and mitomycin C prophylaxis in stage TA and T1transitional cell carcinoma of the bladder","author":"Lamm","year":"1993"},{"key":"10.1002\/14651858.CD003231-BIB16|cit16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-5347(01)65853-1","article-title":"A randomised prospective study comparing intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma","volume":"156","author":"Lundholm","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB17|cit17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1464-410X.1994.tb07604.x","article-title":"Prognostic factors in pTa-pT1 superficial bladder cancer","volume":"73","author":"Mulders","year":"1994","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB18|cit18","first-page":"271","article-title":"Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer","volume-title":"EORTC Genitourinary Group Monograph 6: BCG in Superficial Bladder Cancer","author":"Rintala","year":"1989"},{"key":"10.1002\/14651858.CD003231-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0022-5347(01)66691-6","article-title":"Alternating mitomycin C and bacillus Calmette -Guerin instillation therapy for carcinoma in situ of the bladder","volume":"154","author":"Rintala","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB20|cit20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(01)65936-6","article-title":"Alternating mitomycin C and bacillus Calmette-Gu\u00e9rin instillations prophylaxis for recurrent papillary (stages Ta and T1) superficial bladder cancer","volume":"156","author":"Rintal","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB21|cit21","first-page":"27","volume-title":"International Society of Urological Reports, Immunotherapy of Urological Tumours","author":"Rubben","year":"1990"},{"key":"10.1002\/14651858.CD003231-BIB22|cit22","first-page":"285","article-title":"BCG-RIVM versus BCG-TICE versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, the Netherlands","volume-title":"EORTC Genitorurinary Group Monograph 6: BCG in Superficial Bladder Cancer","author":"Meijden","year":"1989"},{"key":"10.1002\/14651858.CD003231-BIB23|cit23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomised study of intravesical mitomycin C bacillus Calmette-Guerin TICE and bacillus Calmete-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"Vegt","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB24|cit24","first-page":"59","article-title":"BCG-RIVM versus BCG-TICE versus mitomycin C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South East Cooperative Urological Group, The Netherlands.","volume-title":"EORTC Genitourinary Group Monograph 11: Recent Progress in Bladder and Kidney Cancer","author":"Witjes","year":"1992"},{"issue":"12","key":"10.1002\/14651858.CD003231-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0959-8049(93)90102-L","article-title":"A randomised prospective study comparing intravesical instillations of mitomycin C, BCG-TICE, and BCG-RIVM in pTa - pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Group","volume":"29A","author":"Witjes","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD003231-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0022-5347(01)62377-2","article-title":"Results of a randomised phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer","volume":"160","author":"Witjes","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB27|cit27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1078-1439(99)00015-0","article-title":"Intravesical chemotherapy and immunotherapy for superficial tumours: Basic mechanism of action and future direction","volume":"4","author":"Akaza","year":"1998","journal-title":"Urologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003231-BIB28|cit28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000474798","article-title":"4'epidoxirubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer","volume":"21","author":"Silva","year":"1992","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD003231-BIB29|cit29","first-page":"435","article-title":"BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer","volume-title":"Therapeutic Prog Urol Cancers","author":"Debruyne","year":"1989"},{"key":"10.1002\/14651858.CD003231-BIB30|cit30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.308.6923.257","article-title":"Proposal for changes in cystoscopic follow-up of patients with bladder cancer and adjuvant intravesical chemotherapy","volume":"308","author":"Hall","year":"1994","journal-title":"Br Med J"},{"key":"10.1002\/14651858.CD003231-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0022-5347(17)42052-0","article-title":"Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: A phase III prospective randomised trial.","volume":"140","author":"Henney","year":"1988","journal-title":"Journal of Urology"},{"issue":"Suppl 161","key":"10.1002\/14651858.CD003231-BIB32|cit32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jcb.240501322","article-title":"Intravesical BCG: Current results, natural history and implications for urothelial cancer prevention","author":"Herr","year":"1992","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10.1002\/14651858.CD003231-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical Bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomised trial","volume":"13","author":"Herr","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003231-BIB34|cit34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1464-410X.1987.tb09134.x","article-title":"Instillation of mitomycin C and doxorubicn in the prevention of recurrent superficial (Ta - T1) bladder cancer","volume":"60","author":"Jauhiainen","year":"1987","journal-title":"British Journal of Urology"},{"issue":"11","key":"10.1002\/14651858.CD003231-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder cancer","volume":"31A","author":"Kurth","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1002\/14651858.CD003231-BIB36|cit36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)46972-2","article-title":"Bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"134","author":"Lamm","year":"1985","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB37|cit37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/jnci\/83.10.682","article-title":"Adjuvant intravesical pharmacotherapy for superficial bladder cancer","volume":"83","author":"Lum","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/14651858.CD003231-BIB38|cit38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavity bacillus Calmette-Guerin in the treatment of superficial bladder tumours","volume":"137","author":"Morales","year":"1976","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003231-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003231-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(01)65396-5","article-title":"A combined analysis of European Organisation for Research and Treatment of Cancer, and Medical Research Council randomised clinical trials for the prophylactic treatment of stage Ta T1 bladder cancer","volume":"156","author":"Pawinski","year":"1996","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD003231-BIB41|cit41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001986","article-title":"Intravesical Bacillus Calmette-Guerin in Ta and Ta1 Bladder Cancer","author":"Shelley","year":"2000","journal-title":"Cochrane Library of Systematic Reviews"},{"key":"10.1002\/14651858.CD003231-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","article-title":"Bladder cancer guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis)","volume":"162","author":"Smith","year":"1999","journal-title":"Journal of Urology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003231.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"record-id":"31890"},{"DOI":"10.1002\/14651858.cd003231.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003231\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:17:48Z","timestamp":1628543868000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003231"}},"subtitle":[],"editor":[{"given":"Mike","family":"Shelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003231","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD003231.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2003,7,21]]}}}